Press release
Smoking Cessation Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | AstraZeneca, Camino Pharma, CTC Bio, GlaxoSmithKline, Novo Nordisk, Pfizer, Achieve Life Sciences
"Smoking Cessation Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Smoking Cessation Therapeutics Market.
The report provides a detailed description of the Smoking Cessation drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Smoking Cessation Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/smoking-cessation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Smoking Cessation Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Smoking Cessation therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Smoking Cessation treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Smoking Cessation drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Smoking Cessation treatment market.
Learn More about the Clinical and Commercial Development Activities in the Smoking Cessation Therapeutics Domain @
https://www.delveinsight.com/report-store/smoking-cessation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Smoking Cessation Therapeutics Analysis
Quitting smoking causes strong cravings for cigarettes and also symptoms such as anxiety, depression (mostly mild, but sometimes severe), inability to concentrate, irritability, restlessness, hunger, tremor, sweating, dizziness, headaches, abdominal pains, nausea, and disrupted sleep. Nicotine withdrawal symptoms tend to be most intense in the first 2-3 days of going smoke-free and then subside within 2-4 weeks. Drugs are available to reduce the symptoms of nicotine withdrawal.
There are effective treatments that support tobacco cessation, including both behavioral therapies and medications. There are 89 distinct products and services available today for smoking cessation, alongside 12 smoking alternatives that are not specifically indicated for cessation. FDA-approved pharmacotherapies include various forms of nicotine replacement therapy (NRT) in the form of a transdermal patch, gum, nasal spray, oral inhaler, and lozenges; bupropion; and, most recently, varenicline. Nortriptyline and clonidine have been shown in clinical trials to promote smoking cessation, but regulatory authorities have not approved them for this purpose.
There are approx. 13+ key companies developing therapies for Smoking Cessation. Currently, Embera Neuro Therapeutics, Inc. is leading the therapeutics market with its Smoking Cessation drug candidates in the most advanced stage of clinical development.
Smoking Cessation Companies in the Therapeutics Market Include:
• Achieve Life Sciences
• AstraZeneca
• Axsome Therapeutics
• Boryung Pharmaceutical
• Camino Pharma
• Chronic Airway Therapeutics
• CTC Bio
• Embera NeuroTherapeutics, Inc.
• Eolas Therapeutics
• GlaxoSmithKline
• Novo Nordisk
• Pfizer
• Smoke Free Therapeutics (NFL Biosciences SAS)
And Many Others
Emerging and Marketed Smoking Cessation Therapies Covered in the Report Include:
• EMB-001: Embera NeuroTherapeutics, Inc.
• SBP 9330: Camino Pharma
And Many More
Get an in-depth Assessment of the Emerging Therapies and Smoking Cessation Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/smoking-cessation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Smoking Cessation Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Smoking Cessation pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal
Molecule Type
Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule
Request for Sample PDF to Understand More About the Smoking Cessation Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/smoking-cessation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Smoking Cessation Current Treatment Patterns
4. Smoking Cessation - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Smoking Cessation Late-Stage Products (Phase-III)
7. Smoking Cessation Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Smoking Cessation Discontinued Products
13. Smoking Cessation Product Profiles
14. Smoking Cessation Companies
15. Smoking Cessation Drugs
16. Dormant and Discontinued Products
17. Smoking Cessation Unmet Needs
18. Smoking Cessation Future Perspectives
19. Smoking Cessation Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/smoking-cessation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Tenosynovitis Market
https://www.delveinsight.com/report-store/tenosynovitis-market
Checkpoint Inhibitor Refractory Cancer Market
https://www.delveinsight.com/report-store/checkpoint-inhibitor-refractory-cancer-market
Encephalomyelitis Market
https://www.delveinsight.com/report-store/encephalomyelitis-market
FENEBRUTINIB Market
https://www.delveinsight.com/report-store/fenebrutinib-emerging-insight-and-market-forecast
Non-Muscle Invasive Bladder Cancer Market
https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market
Nrg1 Fusion Cancer Pipeline Insight
https://www.delveinsight.com/report-store/nrg1-fusion-cancer-pipeline-insight
Acute Pyelonephritis Market
https://www.delveinsight.com/report-store/acute-pyelonephritis-market
Chronic Refractory Gout Market
https://www.delveinsight.com/report-store/chronic-refractory-gout-market
Complicated Urinary Tract Infections Market
https://www.delveinsight.com/report-store/complicated-urinary-tract-infections-market
Congestive Heart Failure (CHF) Market
https://www.delveinsight.com/report-store/congestive-heart-failure-market
Glomerulonephritis Market
https://www.delveinsight.com/report-store/glomerulonephritis-market
Metastatic Uveal Melanoma (MUM) Market
https://www.delveinsight.com/report-store/metastatic-uveal-melanoma-mum-market
Musculoskeletal Pain Market
https://www.delveinsight.com/report-store/musculoskeletal-pain-market
Recurrent Head And Neck Cancer Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/recurrent-head-and-neck-cancer-squamous-cell-carcinoma-market
Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market
Limb Girdle Muscular Dystrophy (LGMD) Market
https://www.delveinsight.com/report-store/limb-girdle-muscular-dystrophy-lgmd-market
Lower-Limb Spasticity Market
https://www.delveinsight.com/report-store/lower-limb-spasticity-market
Hemiplegia Market
https://www.delveinsight.com/report-store/hemiplegia-market
Global Kinase Inhibitor in Autoimmune Diseases Market
https://www.delveinsight.com/report-store/global-kinase-inhibitor-in-autoimmune-diseases-market
Hereditary Spastic Paraplegias Market
https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market
Amebiasis Market
https://www.delveinsight.com/report-store/amebiasis-market
Galactosemia Market
https://www.delveinsight.com/report-store/galactosemia-market
Generalized Pustular Psoriasis Market
https://www.delveinsight.com/report-store/generalized-pustular-psoriasis-market
Hepatic Impairment Market
https://www.delveinsight.com/report-store/hepatic-impairment-market
Tuberous Sclerosis Complex Market
https://www.delveinsight.com/report-store/tuberous-sclerosis-complex-market
Amyloidosis Market
https://www.delveinsight.com/report-store/amyloidosis-market
BRAF-Mutant Metastatic Melanoma Market
https://www.delveinsight.com/report-store/braf-mutant-metastatic-melanoma-market
Candidemia Market
https://www.delveinsight.com/report-store/candidemia-market
Hepatitis D Market
https://www.delveinsight.com/report-store/hepatitis-d-market
Hyperkalemia Market
https://www.delveinsight.com/report-store/hyperkalemia-market
Vasomotor symptoms (Hot flashes/Night sweats) Market
https://www.delveinsight.com/report-store/vasomotor-symptoms-market
Balloon Valvuloplasty Device Market
https://www.delveinsight.com/report-store/balloon-valvuloplasty-market
Choroideremia Market
https://www.delveinsight.com/report-store/choroideremia-market
Chronic Hand Eczema Market
https://www.delveinsight.com/report-store/chronic-hand-eczema-market
Complex Regional Pain Syndrome Market
https://www.delveinsight.com/report-store/complex-regional-pain-syndrome-crps-market
Diffuse Large B-cell Lymphoma Market
https://www.delveinsight.com/report-store/diffuse-large-b-cell-lymphoma-market
Hypersomnia Market
https://www.delveinsight.com/report-store/hypersomnia-market
Lamellar Ichthyosis (LI) Market
https://www.delveinsight.com/report-store/lamellar-ichthyosis-market
Ulcerative Colitis (UC) Market
https://www.delveinsight.com/report-store/ulcerative-colitis-uc-market
Vernal Keratoconjunctivitis Market
https://www.delveinsight.com/report-store/vernal-keratoconjunctivitis-market-insight
Endocarditis Market
https://www.delveinsight.com/report-store/endocarditis-market
Essential Thrombocythemia (ET) Market
https://www.delveinsight.com/report-store/essential-thrombocythemia-et-market-insights
Hepatorenal Syndrome Market
https://www.delveinsight.com/report-store/hepatorenal-syndrome-market
Pancreatic Ductal Carcinoma Market
https://www.delveinsight.com/report-store/pancreatic-ductal-carcinoma-market
Tenosynovial Giant Cell Tumors (TSGCTs) Market
https://www.delveinsight.com/report-store/tenosynovial-giant-cell-tumors-tsgcts-market
Trauma Fixation Devices Market
https://www.delveinsight.com/report-store/trauma-devices-market
Usher Syndrome Market
https://www.delveinsight.com/report-store/usher-syndrome-market
Vulvar Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/vulvar-squamous-cell-carcinoma-market
Wide Neck Bifurcation Intracranial Aneurysms Market
https://www.delveinsight.com/report-store/wide-neck-bifurcation-intracranial-aneurysms-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Smoking Cessation Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | AstraZeneca, Camino Pharma, CTC Bio, GlaxoSmithKline, Novo Nordisk, Pfizer, Achieve Life Sciences here
News-ID: 3312192 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Smoking
FREESMO's 30-Day No Smoking Challenge: Stop Smoking This VApril
Bristol, UK - 26th March 2025
FREESMO is helping smokers make the switch this VApril with its 30-Day No Smoking Challenge - a structured, motivational program designed to support those looking to stop cigarettes for good. Coinciding with the UK's biggest vaping awareness campaign, the challenge offers tailored guidance, a supportive community, and incentives to keep participants committed.
Smokers are invited to complete FREESMO's unique Smoke-Free Questionnaire - a personalized tool matching…
Smoking Products & Smoking Alternatives Market Growing Popularity and Emerging T …
The global Smoking Products & Smoking Alternatives market size is estimated to be $859.1 billion in 2023, and HTF MI analysts predict it will reach $1046.7 billion by 2031, growing at a CAGR of 2.5% during the forecast period from 2023 to 2031.
Latest Study on Industrial Growth of Global Smoking Products & Smoking Alternatives Market 2024-2030. A detailed study accumulated to offer the Latest insights about acute features of the…
Smoking Products and Smoking Alternatives Market CAGR of 6.6 % Forecast 2030
Smoking products and smoking alternatives play a significant role in curing several human problems such as thyroid, stress relief, and others. This has been helping the market along with other major factors. The factor of growing smoking culture which drives hookah cafes and smoking lounges across the globe. Such a factor will upsurge the prevalence of smoking among youths and adults.
Browse Related Reports:
https://www.databridgemarketresearch.com/reports/global-smoking-products-and-smoking-alternatives-market
Top Trending Reports:
https://researchmarketpapers.blogspot.com/2023/11/cryptocurrency-banking-market-growth.html
https://researchmarketpapers.blogspot.com/2023/11/construction-and-demolition-waste.html
https://1234submission1234.blogspot.com/2023/11/smoking-products-and-smoking.html
Smoking products involves act…
Smoking Products and Smoking Alternatives Market Trajectory, Analytics Report, A …
Smoking products and smoking alternatives play a significant role in curing several human problems such as thyroid, stress relief, and others. This has been helping the market along with other major factors. The factor of growing smoking culture which drives hookah cafes and smoking lounges across the globe. Such a factor will upsurge the prevalence of smoking among youths and adults.
Full Access Of Report:
https://www.databridgemarketresearch.com/reports/global-smoking-products-and-smoking-alternatives-market
Top Trending Reports:
https://predatascience1234.blogspot.com/2023/09/acrylic-coating-additives-market.html
https://predatascience1234.blogspot.com/2023/09/advanced-packaging-technologies-market_28.html
https://predatascience1234.blogspot.com/2023/09/smoking-products-and-smoking_28.html
Data Bridge Market Research analyses…
Smoking Products and Smoking Alternatives Market Size, Share, Forecast, & Indust …
Data Bridge Market Research analyses that the global smoking products and smoking alternatives market is expected to reach a value of USD 1,491,228.44 million by 2030, at a CAGR of 6.6% during the forecast period. The global smoking products and smoking alternatives market report also comprehensively covers pricing analysis, patent analysis, and technological advancements.
Full Access Of Report:
https://www.databridgemarketresearch.com/reports/global-smoking-products-and-smoking-alternatives-market
Top Trending Report:
https://predatascience1234.blogspot.com/2023/09/radio-frequency-rf-diplexer-market.html
https://predatascience1234.blogspot.com/2023/09/security-system-at-workplace-market.html
https://predatascience1234.blogspot.com/2023/09/semiconductor-packaging-materials.html
https://predatascience1234.blogspot.com/2023/09/process-analytics-service-market.html
Smoking products involves act of inhaling and exhaling the fumes of…
Rising Awareness about Smoking Health Hazards and Smoking Cessation Therapy Driv …
The Centers for Disease Control and Prevention (CDC) reported that there were 44 million adults addicted to smoking in 2011 in the U.S. The majority of these addicts belonged to the low-income groups in the country. On a similar note, the World Health Organization stated that Europe has the biggest pool of smokers, while Asia Pacific has a high percentage of cigarette smokers in comparison to North America and Europe.…
